Intelligent Medicine Acquisition Corp. Class A Common Stock
IQMD
IQMD was delisted on the 26th of April, 2023.
61 hedge funds and large institutions have $201M invested in Intelligent Medicine Acquisition Corp. Class A Common Stock in 2022 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 11 increasing their positions, 10 reducing their positions, and 6 closing their positions.
50% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 6
24% more capital invested
Capital invested by funds: $162M → $201M (+$39.4M)
16.94% more ownership
Funds ownership: 77.56% → 94.5% (+17%)
10% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 10
5% more funds holding
Funds holding: 58 → 61 (+3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Calamos Advisors
Naperville,
Illinois
|
+$12.7M |
| 2 |
HIM
HGC Investment Management
Toronto,
Ontario, Canada
|
+$8.13M |
| 3 |
CC
Centiva Capital
New York
|
+$6.3M |
| 4 |
CCA
Castle Creek Arbitrage
Avon,
Colorado
|
+$4.06M |
| 5 |
KIM
Karpus Investment Management
Pittsford,
New York
|
+$2.22M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
-$1.61M |
| 2 |
SC
Sculptor Capital
New York
|
-$1.03M |
| 3 |
WAM
Weiss Asset Management
Boston,
Massachusetts
|
-$762K |
| 4 |
BCM
Basso Capital Management
Stamford,
Connecticut
|
-$557K |
| 5 |
Citigroup
New York
|
-$504K |
IQMD Hedge Fund Activity: Q4 2022 in Review
61 of the 6,238 institutional investors tracked by Wall St. Rank reported a position in Intelligent Medicine Acquisition Corp. Class A Common Stock (IQMD) for Q4 2022, worth a combined $201M — up 24% from $162M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new IQMD positions and 6 closed out — a net gain of 3 holders — while 11 added to existing stakes and 10 trimmed.
The largest buyer was Calamos Advisors, opening a new position worth an estimated $12.7M. The largest seller was Periscope Capital, cutting an estimated $1.61M.
- 61 institutional investors held Intelligent Medicine Acquisition Corp. Class A Common Stock (IQMD) as of Q4 2022, up from 58 in Q3 2022.
- Funds reported $201M of Intelligent Medicine Acquisition Corp. Class A Common Stock stock for Q4 2022, up 24% quarter-over-quarter.
- 9 funds opened new Intelligent Medicine Acquisition Corp. Class A Common Stock positions in Q4 2022 and 6 closed out, a net change of +3 holders.
- The largest Intelligent Medicine Acquisition Corp. Class A Common Stock buyer in Q4 2022 was Calamos Advisors, an estimated $12.7M added.
- The largest Intelligent Medicine Acquisition Corp. Class A Common Stock seller in Q4 2022 was Periscope Capital, an estimated $1.61M sold.
Based on aggregated 13F filings for Q4 2022.